Marc Olivier Perret - Net Worth and Insider Trading
Marc Olivier Perret Net Worth
The estimated net worth of Marc Olivier Perret is at least $832,899 dollars as of 2024-09-21. Marc Olivier Perret is the Director, 10% Owner of Conatus Pharmaceuticals Inc and owns about 1,487,320 shares of Conatus Pharmaceuticals Inc (CNAT) stock worth over $832,899. Details can be seen in Marc Olivier Perret's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marc Olivier Perret has not made any transactions after 2013-07-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Marc Olivier Perret
Marc Olivier Perret Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Marc Olivier Perret owns 2 companies in total, including Histogen Inc (HSTO) , and BG Medicine Inc (BGMD) .
Click here to see the complete history of Marc Olivier Perret’s form 4 insider trades.
Insider Ownership Summary of Marc Olivier Perret
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HSTO | Histogen Inc | 2013-07-24 | director & 10 percent owner |
| BGMD | BG Medicine Inc | 2012-04-17 | 10 percent owner |
Marc Olivier Perret Latest Holdings Summary
Marc Olivier Perret currently owns a total of 1 stock. Marc Olivier Perret owns 1,487,320 shares of Conatus Pharmaceuticals Inc (CNAT) as of July 30, 2013, with a value of $832,899.
Latest Holdings of Marc Olivier Perret
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNAT | Conatus Pharmaceuticals Inc | 2013-07-30 | 1,487,320 | 0.56 | 832,899 |
Holding Weightings of Marc Olivier Perret
Marc Olivier Perret Form 4 Trading Tracker
According to the SEC Form 4 filings, Marc Olivier Perret has made a total of 0 transactions in Conatus Pharmaceuticals Inc (CNAT) over the past 5 years. The most-recent trade in Conatus Pharmaceuticals Inc is the sale of 352 shares on July 30, 2013, which brought Marc Olivier Perret around $3,872.
Insider Trading History of Marc Olivier Perret
- 1
Marc Olivier Perret Trading Performance
Marc Olivier Perret Ownership Network
Marc Olivier Perret Owned Company Details
What does Histogen Inc do?
Who are the key executives at Histogen Inc?
Marc Olivier Perret is the director & 10 percent owner of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .
Histogen Inc (HSTO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Histogen Inc (HSTO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Histogen Inc Insider Transactions
Marc Olivier Perret Mailing Address
Above is the net worth, insider trading, and ownership report for Marc Olivier Perret. You might contact Marc Olivier Perret via mailing address: C/o Bg Medicine, Inc., 610 Lincoln Street North, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
